Publications To Date


    Filter Publications

    PAGE 1 OF 52 | DISPLAYING 1 - 15 OF 766 RESULTS

    Lopez-Knowles E. et. al., Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations, 10.1038/s41416-018-0345-x, Br. J. Can, Dec 19, 2018

    Hisamatsu T. et. al., PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer, 10.1158/1535-7163.MCT-17-1050, Mol. Can. Ther., Dec 18, 2018

    El Jamal S.M. et. al., MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type,, Lab Invest., Dec 17, 2018

    Cui T. et. al., miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma,, Oncogene, Dec 17, 2018

    Aronchik I. et. al., Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance, 10.1158/1541-7786.MCR-17-0554, Mol. Can. Res., Dec 12, 2018

    Lim J. et. al., Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3, 10.1038/sdata.2018.283, Sci. Data, Dec 11, 2018

    Ennishi D. et. al., Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma., 10.1200/JCO.18.01583., J. Clin. Oncol., Dec 03, 2018

    Goschzik T. et. al., Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial, 10.1016/S1470-2045(18)30532-1, Lancet Oncol., Dec 03, 2018

    Mottok A. et. al., Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens, 10.1182/blood-2018-05-851154 , Blood, Dec 01, 2018

    Lambros L. et. al., NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?, 10.5858/arpa.2018-0251-LE., Arch Pathol Lab Med., Dec 01, 2018

    Hillen L.M. et. al., Molecular profiling of Spitz nevi identified by digital RNA counting., 10.1097/CMR.0000000000000495., Melanoma Res., Dec 01, 2018

    Menon D.R. et. al., CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma, 10.1158/0008-5472.CAN-18-0330, Cancer Res., Dec 01, 2018

    Fan K. et. al., Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma, 10.1158/1078-0432.CCR-18-1184, Clin. Can Res., Dec 01, 2018

    Tanaka H. et. al., Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer, 10.1158/1535-7163.MCT-17-1180, Mol. Can. Ther., Dec 01, 2018

    Tasdemir N. et. al., Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures, 10.1158/0008-5472.CAN-18-1416, Cancer Res., Nov 29, 2018